|
Sorry Sir, health insurance can't pay for that! You're not covered! Part 2First a word of caution. This article does not describe any specific health insurance policy. The terms and conditions issued by insurers do vary so please ensure you check out the precise details of the any policies you are actively ( medical insurance ) considering or already own. Then, after reading this article, you'll know what small print to look out for!Sorry Sir, we can't pay that - it's preventativeYour health insurance is designed to pay for the treatment and cure of medical
But a problem of definition can arise. Occasionally it is arguable whether a treatment is a preventative or a cure. Take the drug Herceptin for example. Research shows that if used in the early stages of breast cancer, Herceptin can halve the incidence of the cancer returning for women who have the particularly virulent form of the illness known as HER2. In this ( home insurance quotes ) situation, is Herceptin being used as a cure or a preventative? Insurers are split on the issue. Legal and General and Axa PPP won't pay the high cost of Herceptin treatment whereas BUPA, WPA, Standard Life Healthcare and Norwich Union will for HER2 patients.
Sorry Sir, we can't pay that - it's a chronic conditionIf an illness or condition is not a long-term problem and can be cured, your health insurer will define it as "acute" and should meet the cost. If your problem is incurable or it's a condition that, despite the right treatment, will suffer from for a long time, then your insurer will define it as "chronic". As soon as an illness is defined as chronic your treatment is no longer insured. But deciding whether a condition is acute or chronic is fraught with potential conflict. The decision and its timing is rarely a cut and dried issue and can lead to conflict between policyholders, insurers and indeed, between Doctors themselves. But what happens when Doctors initially consider a patients' illness to be curable, but then the illness deteriorates and the medical team is forced to change changes its' mind - the condition is now incurable. This can occasionally happen, especially in the treatment of certain types of cancer. In these situations, the illness is initially defined as acute, and the costs are therefore covered, but as soon as it becomes chronic - the medical costs are not insured. This is possible as insurers have the right to reclassify an illness from acute to chronic during treatment. Sorry Sir, we can't pay that - it's too long termThe health insurance will not meet the costs of long-term treatment. But the definition of "long-term" can differ between insurance companies. So you need to check your policy to see how it defines "long-term". This is important because the situation can arise where a course of treatment extends for say twelve months, but the insurer will only pay for nine months. Sorry Sir, we can't pay that - the drug is not approvedTwo of the main reasons for buying Health Insurance are to jump the NHS queues and to get the latest medicines and treatments. But there's a rider. The Government wants to ensure that the financial benefits to the nation from using a new drug outweigh the costs of using it in the NHS. So it established the Institute for Health and Clinical Excellence to approve the use of new drugs by the NHS in England and Wales (an equivalent also exists in Scotland). The problem is that the Institute's brief is to perform a complex cost/benefit analysis - a difficult brief and it has placed the Institute under scrutiny for the extended delays in drug approval. This impacts on private health insurance as many insurers have taken the view that until the Institute approves a drug, they will not pay for its use. These delays can create conflict between patient and their insurer where a drug has been proven to be beneficial for a condition but where the Institute for Health and Clinical Excellence has not given approval for its use. The compromise arrived at by the Financial Ombudsman is that if your insurer won't pay for a drug, then if the experimental treatment is more expensive, the insurer should meet the cost of an approved conventional treatment with the policyholder paying the balance.
The basic principle is that if you have already suffered from a condition before you start a policy, then that condition "pre-exists" the policy. Thereafter, any claims for treatment of that condition are invalid. |
|